New "gene therapy" for $4M/treatment approved for an "ultra rare" "genetic" condition

Laundering of vaccine injuries for gaslighting and profit

According to the Endpoint News:

Orchard Therapeutics’ ultra-rare disease drug Lenmeldy is vaulting to the list of most expensive drugs ever with a wholesale acquisition cost of $4.25 million for the one-time treatment in the US.

The company announced the price Wednesday following Lenmeldy’s FDA approval earlier this week, saying that it reflects “its clin…